Popular Articles

Kaiser Permanente Calls For Health Policy Support And Community Advocacy To Curb Childhood Obesity
Kaiser Permanente"s presence this week at the National Childhood Obesity Conference in Los Angeles highlights the need for a comprehensive and multi-faceted approach to stop the health crisis caused by childhood obesity. More than 15 million children are obese or overweight in the United States, contributing to skyrocketing type 2 diabetes rates and more than $14 billion in health care expenses.

New Noninvasive Technique Monitors Fetal Heartbeat
Tiny fluctuations in a fetus"s heartbeat can indicate distress, but currently there is no way to detect such subtle variations except during labor, when it could be too late to prevent serious or even fatal complications.
News of the day
Need For Reform Is Urgent, Health Care Leaders Say
By a wide margin, health care leaders believe that individuals should have a choice of public and private health plans, and strongly support other central components of health reform such as innovative provider payment reform and a national insurance health exchange with strong standard-setting authority. In addition, two-thirds (68%) of opinion leaders feel it is urgent to enact comprehensive health care reform this year, according to the latest Commonwealth Fund/Modern Healthcare Health Care Opinion Leaders Survey.
Medical Devices

APhA Publishes Reference On Drugs And Substances Of Abuse

The American Pharmacists Association (APhA) will publish in mid-July the second edition of Pagliaros" Comprehensive Guide to Drugs and Substances of Abuse. Written by veteran authors Louis A. Pagliaro and Ann Marie Pagliaro, the reference includes more than 100 monographs-11 of them new-dealing with each of the major drugs and substances of abuse used in North America, from acetone to zopiclone. Each monograph lists generic synonyms, brand or trade names, chemical names, "street" names, and pharmacologic classification. After a brief overview of the drug or substance of abuse, with attention to its , history, and patterns of use, the following key features are clearly and concisely presented: - Available dosage forms and common routes and methods of administration - Mechanisms of action and related pharmacology - Currently approved indications for medical use - Desired actions or reasons for personal use - Toxicity, including acute and chronic adverse effects - Potential for physical and psychological dependence - Related withdrawal syndromes, including signs and symptoms - Information concerning overdosage and its general management, including the availability of specific antidotes The reference is intended for health care providers, especially specialists in treatment of drug and substance abuse; students of pharmacy, medicine, nursing, and other allied health fields; law enforcement personnel; emergency responders; mental health counselors; and social workers. Louis A. Pagliaro, MS, PharmD, PhD, is a former professor (Pharmacy, Pharmaceutical Sciences, and Pharmacopsychology). Ann Marie Pagliaro, BSN, MSN, PhD candidate, is a former professor (Nursing) and director of the Substance Abusology and Clinical Pharmacology Research Group. Both held positions for over 30 years as tenured academic staff at the University of Alberta before retiring in 2008, and both now are Professors Emeriti. They have published widely and are known both nationally and internationally as leading authorities in the field of drug and substance abuse. They continue to consult for many public and private organizations. This is their 15th textbook. American Pharmacists Association (APhA)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):